SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-17-000050
Filing Date
2017-05-15
Accepted
2017-05-15 06:55:20
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q blph03311710q.htm 10-Q 650399
2 EXHIBIT 31.1 blph03311710-qexhibit311.htm EX-31.1 9903
3 EXHIBIT 31.2 blph03311710-qexhibit312.htm EX-31.2 9881
4 EXHIBIT 32 blph03311710-qexhibit32.htm EX-32 10866
  Complete submission text file 0001600132-17-000050.txt   3772126

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20170331.xsd EX-101.SCH 37313
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20170331_def.xml EX-101.DEF 193031
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20170331_lab.xml EX-101.LAB 490974
8 XBRL INSTANCE DOCUMENT blph-20170331.xml EX-101.INS 590212
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20170331_cal.xml EX-101.CAL 48151
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20170331_pre.xml EX-101.PRE 299088
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 17840981
SIC: 2834 Pharmaceutical Preparations